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Abstract
Gastric lactobezoar, a pathological conglomeration of milk and mucus in the stomach of milk-fed infants often
causing gastric outlet obstruction, is a rarely reported disorder (96 cases since its first description in 1959). While
most patients were described 1975-1985 only 26 children have been published since 1986. Clinically, gastric
lactobezoars frequently manifest as acute abdomen with abdominal distension (61.0% of 96 patients), vomiting
(54.2%), diarrhea (21.9%), and/or a palpable abdominal mass (19.8%). Respiratory (23.0%) and cardiocirculatory
(16.7%) symptoms are not uncommon. The pathogenesis of lactobezoar formation is multifactorial: exogenous
influences such as high casein content (54.2%), medium chain triglycerides (54.2%) or enhanced caloric density
(65.6%) of infant milk as well as endogenous factors including immature gastrointestinal functions (66.0%),
dehydration (27.5%) and many other mechanisms have been suggested. Diagnosis is easy if the potential presence
of a gastric lactobezoar is thought of, and is based on a history of inappropriate milk feeding, signs of acute
abdomen and characteristic features of diagnostic imaging. Previously, plain and/or air-, clear fluid- or opaque
contrast medium radiography techniques were used to demonstrate a mass free-floating in the lumen of the
stomach. This feature differentiates a gastric lactobezoar from intussusception or an abdominal neoplasm.
Currently, abdominal ultrasound, showing highly echogenic intrabezoaric air trapping, is the diagnostic method of
choice. However, identifying a gastric lactobezoar requires an investigator experienced in gastrointestinal problems
of infancy as can be appreciated from the results of our review which show that in not even a single patient
gastric lactobezoar was initially considered as a possible differential diagnosis. Furthermore, in over 30% of plain
radiographs reported, diagnosis was initially missed although a lactobezoar was clearly demonstrable on repeat
evaluation of the same X-ray films. Enhanced diagnostic sensitivity would be most rewarding since management
consisting of cessation of oral feedings combined with administration of intravenous fluids and gastric lavage is
easy and resolves over 85% of gastric lactobezoars. In conclusion, gastric lactobezoar is a disorder of unknown
prevalence and is nowadays very rarely published, possibly because of inadequate diagnostic sensitivity and/or not
yet identified but beneficial modifications of patient management.
Keywords: gastric lactobezoar, formula preparation, acute abdomen, dehydration, immature gastrointestinal func-
tions, underdiagnosed entity, conservative management
Introduction
Gastric lactobezoar (GLB) is a type of acid-insoluble
bezoar characterized by its composition of milk and
mucus components [1] and localization in the stomach
as a free-floating lump. Lactobezoars also differ from
other bezoar types such as tricho-, phyto-, mixed food-
or medication-bezoars [2] by their almost invariable
occurrence during early age, indeed the majority of lac-
tobezoars reported in the literature has been diagnosed
in premature neonates [2-5]. While most lactobezoars
are located in the stomach, some of them have also
been found in the upper [6-8] and lower intestine [9],
all of them being manifestations of the inspissated milk
syndrome [10]. No genetic associations have been
reported so far.
This paper summarizes data of 96 patients with GLB
from 40 publications identified by searches in PubMed,
EMBASE, DIALINDEX, Biosis Previews, CAB Abstracts,
Pascal, Sci Search, American Academy of Pediatrics
Search Site, JSTOR, LactMed, Lange Case Files, Up To
Date, Ovid and Cochrane data bases. Our major purpose
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der, 2) alert physicians to the possibility that GLB may
be a differential diagnosis of acute abdomen, 3) discuss
why GLBs are now so rarely reported, and 4) emphasize
early conservative treatment instead of primary endo-
scopic or surgical interventions.
Epidemiology
The true prevalence of GLB is unknown. Most of the
96 cases reported were diagnosed in North American
Hospitals (USA 76 patients, Canada 1). Additional
patients were published by authors from South Africa
(4), France (4), UK (4), Austria (3), Germany (1), Israel
(1), The Netherlands (1) and Saudi Arabia (1). Of the
51 cases, in whom gender was reported, 22 were
females, 29 males. 61 of the8 7p a t i e n t s( 7 0 . 1 % ) ,i n
whom the age at manifestation of the GLB was docu-
mented, were 30 days old or younger. In 20 further
patients a GLB became manifest between 31 and 365
days and in 5 toddlers between the age of 440 and
1080 days. We found only 1 publication on a GLB-
patient beyond toddlers age [11]. Gestational age was
documented in 79.2% (76/96) of the published chil-
dren, of whom 76.7% were born prematurely whereas
23.3% were term. The mean gestational age of these 76
babies was 33 ± 4 weeks (range 24-41) whereby no dif-
ference between females and males was found. Publica-
tions where both the newborn’s gestational age and
birth weight were documented (74/96 patients; 77.1%)
show that 70.7% of these children had a birth weight
appropriate for gestational age whereas 29.3% were
small for gestational age.
Clinical presentation
Clinical symptoms & signs of GLB are summarized in
Table 1. GLBs were found in asymptomatic patients
[3,4] or became manifest by predominantly gastrointest-
inal (GI) symptomatology which affected 77/96, i.e. over
80% of all patients (Table 1). Surprisingly, not a single
patient was reported to have apparent hematemesis
although signs of mechanical irritation and ulceration of
the mucosa by GLB and in 7 cases even gastric perfora-
tion [1,3,4,12] were described. GI symptoms were
accompanied by disturbances of fluid and metabolic bal-
ance in 37/96 children (38.5%). Respiratory symptoms
including apnea were a rather prominent manifestation
and GLB was found to be the only related etiology in at
least 20 reported patients (22.0%), all of them premature
infants [3,4,13,14]. Amongst cardiocirculatory problems,
bradycardia was encountered predominantly in prema-
ture babies while tachycardia prevailed in mature infants
and toddlers, and was in the latter group often asso-
ciated with anemia [15,16]. Neurological [11,17,18] and
infectious/allergic manifestations [4,19] were also
described with GLB although the mechanisms of these
associations are currently not understood.
Pathogenesis
GLBs are thought to result from the coagulation of milk
and mucous proteins following disturbed gastric func-
tion. Observed or postulated conditions favouring GLB
formation included both exogenous and endogenous
factors as summarized in Table 2.
Exogenous influences were related to 1) composition
of formula, 2) medications inhibiting gastric secretion
and motility, 3) modalities of feeding, and 4) conditions
causing dehydration. Data on the composition of GLB
are scarce. Levkoff [1] described a gelatinous,
Table 1 Clinical symptoms & signs of gastric lactobezoar
Symptoms & signs patients
reported
*)
presenting symptom &
sign
*)
No symptoms & signs 5 (5.2) -
Gastrointestinal
Abdominal distension 59 (61.0) 45 (46.9)
Vomiting/regurgitation 52 (54.2) 42 (43.8)
Gastric residuals 26 (27.1) 23 (24.0)
Milk curds 9 (9.4) 2 (2.1)
Palpable abdominal mass 19 (19.8) 4 (4.2)
Weight loss/failure to
thrive
9 (9.4) 1 (1.0)
Diarrhea 21 (21.9) 18 (18.9)
Melena/positive hematest 7 (7.3) 4 (4.2)
Constipation 2 (2.1) -
Fluid/Metabolic
Dehydration 24 (25.0) 8 (8.3)
Increased sweating 1 (1.0) -
Edema 3 (3.1) 1 (1.0)
Metabolic acidosis 1 (1.0) -
Cardiocirculatory/
Respiratory
Respiratory distress 16 (16.7) 7 (7.3)
Apnea 6 (6.3) 4 (4.2)
Cardiocirculatory
symptoms
16 (16.7) 6 (6.3)
Anemia 6 (6.3) 4 (4.2)
Infectious/Allergic
Infection 6 (6.3) -
Fever 6 (6.3) 3 (3.1)
Ekzema 1 (1.0) -
Allergic symptoms&signs 4 (4.2) -
Neurological
Lethargy 7 (7.3) 3 (3.1)
Crying 2 (2.1) 1
Irritability 6 (6.3) 4 (4.2)
Temper tantrums 1 (1.0) -
Cerebral seizures 1 (1.0) 1 (1.0)
*) # show frequencies of parameters indicated in 96 patients from 40
literature reports, numbers in parentheses show percentages per 96 patients
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“protein, few cells, moderate numbers of bacteria, and
crystals of cholesterol, lactose and triple phosphate”.
Later Erenberg [5] found elevated long chain triglyceride
(LCT) and decreased medium chain triglyceride (MCT)
concentrations in GLBs indicating a better absorption of
MCTs by the stomach. Absorbed MCTs delay gastric
emptying [19,20] and thus facilitate GLB formation.
Therefore the introduction of MCT-enriched formula in
the late 1970ies may have been one factor causing a
striking temporary increase of GLB cases at that time
(Figure 1). Why, after 1985, numbers of reported GLB-
patients have - despite continued MCT-rich nutrition -
returned to levels before 1975 will, however, remain dif-
ficult to clarify.
With over-concentrated formula resulting from erro-
neous preparation predominantly during the 1960ies
and 1970ies (Table 2) the content of calories and nutri-
ents clearly exceeded age-related dietary reference
intakes (DRI) [21,22]. This may be particularly true for
protein as can be calculated from the data given in the
literature for at least 9 cases [4,23-26]. Also, the intro-
duction of special LBW formulas may have to do with
protein concentrations too high for the digestive capa-
city of premature infants [27-29]. The quality of milk
protein [10,13] was believed to be another factor in the
formation of GLB: until 1980 commercial milk formulas
contained protein with 80% caseine and 20% whey, con-
trary to human breast milk where this ratio is approxi-
mately 40:60. Because until then lactobezoars had only
been reported in infants fed with these “non-huma-
nized” formulas and not in those with human breast
milk, it was thought useful to adapt the caseine: whey
ratio to that in human milk. While these whey-protein-
predominant formulas were initially reported to prevent
GLB [13] the subsequent years have shown that GLBs
also form with humanized formulas [30] and even with
human breast milk [31].
Besides nutritional factors, medications used to reduce
vomiting and diarrhoea [2,32-34] or to antagonize gas-
tric secretion and motility (Table 2) have been asso-
ciated with GLB formation [2,15,23,32]. These agents
cause increased coagulation of gastric protein leading -
together with elevated concentrations of calcium, phos-
phorus and fat - to curds with enhanced tension as the
basic constituents of GLB [3,10,22].
Modalities of feeding are also discussed: firstly, the
postnatal age at which enteral feeds were started and
the speed at which food volumes and concentrations
were advanced were suspected to influence GLB forma-
tion [3,4,35]. Furthermore, the question whether enteral
continuous drip or intermittent bolus feeding should be
preferred remains undetermined [36] although in this
review we found 34 patients with GLB after enteral con-
tinuous drip but only 22 babies after bolus feeding
(Table 2), suggesting a lower risk in the latter. With
regard to technique, supine body posture during feeding
was associated with air-accumulation in the prepyloric
antrum impeding the passage of gastric content towards
Table 2 Pathogenetic factors reported/postulated with
gastric lactobezoar
Pathogenetic factor reported
*) postulated
$)
Exogenous
“Overconcentrated” formula 18 (18.8) 14 (35.0)
Calorie content > 80 kcal/100 ml 63 (65.6) 6 (15.0)
Special LBW formula 52 (54.2) 10 (25.0)
Breast milk fortifier 4 (4.2) 5 (12.5)
Protein concentration > DRI
#) 9 (9.4) 4 (10.0)
Casein predominance > 60% 52 (54.2) 8 (20.0)
Cow’s milk protein 1 (1.0) 3 (7.5)
Medium chain triglycerides 52 (54.2) 11 (27.5)
Increased Ca-content of formula - 3 (7.5)
Increased Ca/P ratio of formula - 3 (7.5)
Silica (Gelopectose) 3 (3.1) 3 (7.5)
Alginate (Gaviscon) 2 (2.1) 1 (2.5)
Pectin-lignin-cellulose(Aroban) 1 (1.0) 2 (5.0)
Atropin (e.g. Eumydrin
®) 2 (2.1) 3 (7.5)
Antacids (Sucralfate
® Aluminium hydroxide
etc.)
3 (3.1) 5 (12.5)
Modes of feeding - oral - gavage - bolus -
continuous
29 (30.2) 7 (17.5)
Age < 14 days at start of > 80 kcal formula 35 (36.5) 6 (15.0)
Supine body position (poor gastric mixing) 9 (9.4) 3 (7.5)
Phototherapy prior to lactobezoar diagnosis 16 (16.7) 3 (7.5)
Increased sweating (due to hot weather) 1 (1.0) 2 (5.0)
Endogenous
Prematurity 54 (56.3) 21 (52.5)
Low birth weight (< 2500 gm) 52 (54.2) 8 (20.0)
Dehydration 12 (12.5) 11 (27.5)
Increased gastric absorption of fluids - 3 (7.5)
Decreased global gastric secretion 3 (3.1) 2 (5.0)
Interaction of formula with gastric secretion - 2 (5.0)
Increased osmolality of gastric content 1 (1.0) 1 (2.5)
Delayed gastric emptying 3 (3.1) 16 (40.0)
Postprandial time course of gastric acidity - 1 (2.5)
Decreased “digestive capacity” - 3 (7.5)
Decreased enzyme activity - 2 (5.0)
Gastric Ca secretion - 3 (7.5)
Gastric Ca+fat/protein precipitates 1 (1.0) 3 (7.5)
Respiratory distress syndrome 14 (14.6) 6 (15.0)
Birth asphyxia 9 (9.4) 4 (10.0)
Systemic infection 10 (10.4) 4 (10.0)
* ) indicates pathogenetic factors documented in #/96 patients (numbers in
parentheses are percentages per 96 patients)
$ ) indicates postulated factors in 40 literature reports (numbers in
parentheses are percentages per 40 reports)
#) DRI dietary reference intake (age-adapted)
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logical explanation, the literature mentioned only 9
cases of GLB in babies fed in the supine position. A
fourth group of exogenous factors responsible for GLB-
formation were conditions leading to dehydration
including - besides inadequate fluid intake - photother-
apy [30,38] and hot weather [15] (Table 2).
The predominant endogenous risk factors for GLB
formation, prematurity and low birth weight [3,10]
imply many poorly developed essential physiological
functions (Table 2) comprising e.g. low “digestive capa-
city” due to reduced gastric acid production and pepsin
activity [39-41]. These functional insufficiencies may be
d r a s t i c a l l ye n h a n c e db yav e r yl a b i l es t a t eo ft i s s u e
hydration readily permitting the initiation of a vicious
cycle [42]: milk formulae which put too much load
upon the capacities of the GI-tract cause vomiting and/
or diarrhea. This produces diminution of extracellular
fluid volume (dehydration). To accommodate for dehy-
dration, water is excessively absorbed from the GI-tract
which leads to GLB-formation and often gastric outlet
obstruction followed again by vomiting and dehydration.
Diagnosis
The essential criteria for diagnosing GLB are summar-
ized in Table 3. A precise nutritional history was found
to be crucial in revealing mistakes of formula prepara-
tion and feeding modalities [3,4]. Often, reported
decreased intakes or increased losses of fluid explained
GLB-related dehydration which was in more serious
cases even associated with cardiocirculatory problems
[4,23,43]. Signs of respiratory distress were sometimes a
manifestation of mechanical disturbance of lung func-
tion by the bezoar [2,15-17] and were in nearly 20% of
cases associated with a palpable abdominal mass.
Laboratory parameters in the reported patients with
GLB were rather nonspecific (Table 3) and included
analytes reflecting blood loss, which was in a few cases
corroborated by detecting hematest positive stools (5.2%
patients) [3,13,23]. Pathologic parameters of dehydration
and electrolyte disturbance following prolonged vomit-
ing were recorded in 12.5% of patients [15,16,23,43,44].
With regard to diagnostic imaging, abdominal ultra-
sound, reported in 12 cases so far, showed highly echo-
genic intra-bezoaric air trapping [8,16,18,45-47] and
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Plain radiography was the most commonly reported
method (Table 3): however, in 62 patients investigated this
way only 42 GLBs (67.7%) were correctly identified. In the
remaining 20 cases with inconclusive plain abdominal
radiography and in 25 additional patients, air contrast,
clear fluid or opaque contrast medium radiography
[45-47], or X-ray video-recording led to the detection of a
GLB [23,48-50]. In 2 further patients GLBs were first diag-
nosed by gastroscopy [19,46] (Table 3). Notwithstanding,
in 9 patients GLBs were detected during laparotomy
[1,3,12,25]. While gastric perforation was found in 7 of
these patients, pneumoperitoneum was identified by plain
abdominal X-ray in only 4 of them.
GLB may be an underdiagnosed entity. Firstly, abdom-
inal distension and vomiting/regurgitation are often
managed by pausing enteral nutrition and giving intra-
venous fluids which is also the standard treatment for
GLB [2,3,30,32,34,42-44]. This usually leads to complete
dissolution and impossibility of documenting the origi-
nal existence of a GLB. A second cause for underdiag-
nosis is the frequently short livespan of GLBs - even
without treatment - as shown by serial radiological stu-
dies [23,31,34,44]. A third argument is low diagnostic
sensitivity of physicians who have often initially failed to
diagnose GLBs actually present as proven subsequently
by repeat evaluation of the same X-ray film [1,2]
T h u s ,t h ed i a g n o s i so fG L Ba f f o r d sah i g hd e g r e eo f
experience and suspicion. Yet, bearing in mind the rele-
vant diagnostic criteria (Tables 3 and 4) will permit the
correct diagnosis and allow a clear differentiation from
other entities with an abdominal mass (Table 5).
Management
The therapeutic regimen of nil per mouth, with intrave-
nous fluids alone or in combination with gastric lavage
Table 3 Diagnostic parameters obtained in the investigation of gastric lactobezoar
Diagnostic criteria Diagnostic information patients reported
*)
Patient history - calorie content > 80 kcal/100 ml formula 69 (71.9)
- mode/technique of feeding 63 (65.6)
- food additives (milk fortifiers, anti-reflux preparations) 7 (7.3)
- decreased fluid intake/24 hrs 17 (17.7)
- increased fluid loss (vomiting, diarrhea, sweating) 71 (74.0)
- medications antagonizing gastric secretion & motility 7 (7.3)
Physical examination - signs of acute abdomen 67 (69.8)
- palpable abdominal mass 19 (19.8)
- physical signs of dehydration 16 (16.7)
- signs of cardiocirculatory distress 17 (17.7)
- signs of respiratory distress 15 (15.6)
Laboratory - parameters of blood loss (↓ hemoglobin, ferritinetc.) 6 (6.3)
- hematest positive stool 5 (5.2)
- parameters of dehydration (↑ hematocrit, BUN etc.) 12 (12.5)
Diagnostic - abdominal ultrasound imaging 12 (12.5)
- plain abdominal radiography 62 (64.6)
- air contrast radiography 18 (18.8)
- clear fluid feed radiography 14 (14.6)
- opaque contrast medium radiography 10 (10.4)
- X-ray video imaging 13 (13.5)
Gastroscopy 2 (2.1)
Surgery 9 (9.4)
*) Diagnostic parameters reported in # per 96 patients. Numbers in parentheses are percentages per 96 Patients
Table 4 Diagnostic imaging criteria for gastric lactobezoar
Method Diagnostic criteria
Ultrasound free-floating intra-gastric mass, moves with patient positioning, intra-bezoaric echogenic air trapping
Plain X-ray intra-gastric rounded mass only visible when surrounded by sufficient air or fluid, calcifications may be
visible
Air-/fluid contrast opaque contrast
medium
intra-gastric rounded mass large circular filling defect with mottled surface
X-ray video-imaging mass moves with patient positioning
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6). GLB - resolution was even reported in patients in
whom enteral nutrition was continued. Nevertheless,
from the bulk of information obtained in this study, a
decrease in caloric density seems clearly warranted as
soon as first signs of overstraining the individual diges-
tive capacity become apparent. In cases with protracted
GLB-dissolution gastric lavage with 20 to 100 ml phy-
siologic saline 4 × daily and protein-cleaving enzymes
such as N-acetylcysteine at a concentration of 10 mg ×
kg
-1 ×d o s e
-1, was helpful [16]. An important comple-
mentary measure was decompression of the stomach by
a nasogastric tube. The success of conservative treat-
ment clearly argues against primary invasive measures.
However, caution is warranted when the cause of acute
abdomen remains elusive for more than 24 hours as was
the case in the majority of the 7 patients with GLB in
whom gastric perforation finally turned out to have
been a stringent indication for surgery. For 2 additional
infants without perforation the need for laparotomy may
have been viewed differently if the present knowledge of
the state of the art in diagnosis and treatment of GLB
had been available [23,43]. Thus surgical treatment is
only warranted when 1) a pneumoperitoneum is diag-
nosed, 2) the cause for an acute abdomen remains uni-
dentified, or 3) an already diagnosed GLB cannot be
dissolved by conservative management within 72 hours.
In this latter case gastroscopic disintegration may be
tried before surgery if the patient is in good physical
condition [19,10].
Prognosis
GLB has an excellent outcome provided diagnosis and
treatment occur in due time [2,10,17,51]. It is important
to alert pediatricians to the possibility of GLB being a
differential diagnostic entity of acute abdomen. An
improved index of suspicion leads to timely diagnosis
and reduces severe complications and mortality in these
vulnerable kids. Because the response of GLB to treat-
ment can be closely monitored by repeat ultrasound
scans conservative measures are a safe approach and
will in most cases result in complete GLB-resolution
within 2-3 days.
Perspectives for the future
Prospective controlled studies on the great variety of
postulated pathogenetic factors (Table 2) are lacking.
Particularly important issues for study comprise:
1) Pathogenetic factors causing GLB: for example
volumes and concentrations of gastric contents, pH,
osmolality, pepsin activity and indicators of gastric
emptying should be studied under defined condi-
tions (e.g. time points during feeding cycle, formula
Table 5 Differential diagnosis of gastric lactobezoar
Gastrointestinal obstruction Other types of gastric bezoar
Intestinal or colonic bezoar
Pyloric stenosis
Intestinal stenosis/atresia
Paralytic ileus
Meconiumileus
Volvulus
Intussusception
Tumors Tumor of the liver
Tumor of the kidney
Neuroblastoma
GI-lymphoma
Respiratory Infant respiratory distress syndrome
Pneumonia
Pneumothorax
Diaphragmatic hernia
Cardiocirculatory Cardiac malformation
Cardiac insufficiency
Sepsis
Inadequate supply of fluids
Table 6 Reported treatment of patients with gastric lactobezoar
Type of treatment #/96 patients reported
*)
No treatment reported 14 (14.6)
Nil per mouth alone 3 (3.1)
Intravenous fluidsand “nil per mouth” 29 (30.2)
Gastric decompression (nasogastric tube) 64 (66.7)
Gastric lavage 16 (16.7)
Gastric lavage with N-acetylcysteine 3 (3.1)
Intravenous fluids+ continued enteral feeds 4 (4.2)
Change to different milk/formula with “normal” concentration 9 (9.4)
Change to different milk/formula with reduced concentration 6 (6.3)
Mechanical disintegration with feeding tube 4 (4.2)
Gastroscopy 2 (2.1)
Surgery 9 (9.4)
*) Types of treatment in 96 patients with gastric lactobezoar. In some patients more than one type of treatment was reported. Numbers in parentheses are
percentages of patients managed with the indicated modality.
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to identify relevant markers.
2) Evaluation of risk factors associated with gastric
perforation: prematurity was found to be one of
them. However, from the existing publications it was
impossible to decide if a GLB or a nasogastric tube -
or other factors including a delay in diagnosis - were
responsible for the perforation. Therefore prospec-
tive evaluation of these parameters is clearly
warranted.
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BUN: blood urea nitrogen; DRI: dietary reference intake;
GI: gastrointestinal; GLB: gastric lactobezoar; LBW: low
birth weight; LCT: long chain triglyceride; MCT: med-
ium chain triglyceride
Authors’ contributions
PH-E drafted the manuscript. IG contributed information on diagnostic
imaging. AK-F described mechanisms causing anemia in GLB patients. RT
elaborated on neonatal pathophysiology. CN collected and analysed data
from the reviewed literature. TM provided insights in pathophysiological
mechanisms of lactobezoar formation. BM revised the manuscript. VJ and
SSB compiled information on nutritional aspects supporting the formation of
GLB. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 August 2011 Accepted: 4 January 2012
Published: 4 January 2012
References
1. Levkoff AH, Gadsden RH, Hennigar GR, Webb CM: Lactobezoar and gastric
perforation in a neonate. J Pediatr 1970, 77:875-877.
2. Grosfeld JL, Schreiner RL, Franken EA, Lemons JA, Ballantine TVN, Weber TR,
Gresham TL: The changing pattern of gastrointestinal bezoar in infants
and children. Surgery 1980, 88:425-432.
3. Schreiner RL, Brady MS, Franken EA, Stevens DC, Lemons JA, Gresham EA:
Increased incidence of lactobezoars in low birth weight infants. Am J Dis
Child 1979, 133:936-940.
4. Erenberg A, Shaw RD, Yousefzadeh D: Lactobezoar in the low birth
weight infant. Pediatrics 1979, 63:643-646.
5. Erenberg A: Lactobezoar. In Feeding the Neonate Weighing Less than 1500
Grams. Edited by: Sunshine P. Report of the 79th Ross Conference on
Pediatr. Res; 1980:99-102.
6. Towery HH, Chan RK: Lactobezoar: a case report. Clin Pediatr 2004,
43:577-578.
7. Michael A, Sellaraman S: Lactobezoar: a rare cause of ileal obstruction.
Indian Pediatr 2004, 41:1279-1280.
8. Rao PVH, Raveenthiran V, Dhannalakshmi M: Gastric and intestinal
lactobezoars. Ind J Gastroenterol 2001, 20:115-116.
9. Freitas L, Goldszmidt D, Dubousset AM, Valayer J: Occlusion intestinale
basse par lactobezoard. Chir Pediatr 1988, 29:351-352.
10. Corzine M: Radiology case study. Gastric lactobezoar. Neonatal Netw 2011,
180-1.
11. Smith BJ, Bachrach SJ: An unexspected finding in an eight-year-old child
with cerebral palsy and weight loss. J Natl Med Assoc 2006, 98:280-283.
12. Hall NJ, Ward HC: Lactobezoar with perforation in a premature infant.
Biol Neonate 2005, 88:328-330.
13. Schreiner RL, Brady MS, Ernst JA, Lemmons JA: Lack of lactobezoars in
infants given predominantly whey protein formulas. Am J Dis Child 1982,
136:437-439.
14. Usmani SS, Levenbrown J: Lactobezoar in a full-term breast-fed infant.
Am J Gastroenterol 1989, 84:647-649.
15. Sipell WG, Kalb C, Fendel H: Lactobezoar in an infant: an unusual cause of
upper abdominal tumour persisting for several weeks. Eur J Pediatr 1977,
126:97-102.
16. Heinz-Erian P, Klein-Franke A, Gassner I, Kropshofer G, Salvador C, Meister B,
Müller T, Scholl-Bürgi S: Disintegration of large gastric lactobezoars by N-
acetyl- cysteine. J Pediatr Gastroenterol Nutr 2010, 50:108-110.
17. DuBose TM, Southgate VWM, Hill JG: Lactobezoars: A patient series and
literature review. Clin Pediatr 2001, 40:603-606.
18. Kruijdenberg CBM, Mattheij MAC, Runneboom-Mertens SCJ,
Widdershoven JAM: A lactobezoar in an infant with excessive crying: a
case and literature review. Tijdschr Kindergeneeskd 2010, 78:168-171.
19. Lemoh JN, Watt J: Lactobezoar and cow’s milk protein intolerance. Arch
Dis Child 1980, 55:128-129.
20. Hunt JN, Knox MT: A relation between the chain length of fatty acids
and the slowing of gastric emptying. J Physiol 1968, 194:327-336.
21. Groh-Wargo S, Sapsford A: Enteral nutrition support of the preterm infant
in the neonatal intensive care unit. Nutr Clin Pract 2009, 24:363-376.
22. Nutrition of the Preterm Infant. Edited by: Tsang RC, Uauy R, Koletzko B,
Zlotkin S. Cincinnati, OH: Digital Education Publishing; 2005:415-416.
23. Cremin BJ, Fisher RM, Stokes NJ, Rabkin J: Four cases of lactobezoar in
neonates. Pediatr Radiol 1974, 2:107-109.
24. Wexler HA, Poole CA: Lactobezoar, a complication of overconcentrated
milk formula. J Pediatr Surg 1976, 11:261-262.
25. Wolf RS, Bruce J: Gastrotomy for lactobezoar in a newborn infant. J
Pediatr 1959, 54:811-812.
26. Wolf RS, Davis LA: Lactobezoar - a foreign body formed by the use of
undiluted powdered milk substance. JAMA 1963, 184:782.
27. Duritz G, Oltorf C: Lactobezoar formation associated with high-density
caloric formula. Pediatrics 1979, 63:647-649.
28. Sullivan MA, Smith RT: Lactobezoars-a simple therapy. Am J Dis Child 1977,
131:813.
29. Schreiner RL, Lemons JA, Gresham EL: A new complication of
nutritionalmanagement of the low-birth-weight infant. Pediatrics 1979,
63:683-685.
30. Reddy ER, Joseph S: Lactobezoar in a low-birth-weight neonate. Can Med
Assoc J 1985, 133:297.
31. Yoss BS: Human milk lactobezoars. J Pediatr 1984, 105:819-822.
32. Beraud C, Disant F, Ardiet JM: Lactobezoard chez un premature de 9
jours. Rev Internat Pediatr 1979, 94:19-25.
33. Sznajder M, Benichou JJ, Labrune B: Lactobezoard chez un nourisson. Arch
Fr Pediatr 1985, 42:699-700.
34. Faverge B, Gratecos LA: Lactobezoard gastrique du nourrisson induit par
Gelopectose®. Pediatrie 1987, 42:685-686.
35. Berseth CL, Bisquera JA: Prolonging small feeding volumes in early life
decreases the incidence of necrotizing enterocolitis in very low birth
weight infants. Pediatrics 2003, 111:529-534.
36. Premij S, Chessell L: Continuous nasogastric milk feeding versus
intermittent bolus milk feeding for premature infants less than 1500
grams. Cochrane Database Syst Rev 2003, , 1: CD001819.
37. Hood JH: Effect of posture on the amount and distribution of gas in the
intestinal tract of infants and young children. Lancet 1964, 2:107.
38. Tolia V, Dubois RS: Lactobezoar in prematurity. A case with prolonged
resolution. Clin Pediatr 1981, 20:651-653.
39. Miller RA: Observations on the gastric acidity during the first months of
life. Arch Dis Child 1941, 16:22-30.
40. Lawrence RA, Klish WJ, Brown MR: Studies of low birth weight infants
with lactobezoars. Pediatr Res 1980, 14:504.
41. Sangild PT: Gut responses to enteral nutrition in preterm infants and
animals. Exp Biol Med 2006, 231:1695-1711.
42. Majd M, LoPresti JM: Lactobezoar. Am J Roentgenol Rad Ther Nucl Med
1972, 116:575-576.
43. Bakken DA, Abramo TJ: Gastric lactobezoar: a rare cause of gastric outlet
obstruction. Pediatr Emerg 1997, 13:264-267.
44. Singer JI: Lactobezoar causing an abdominal triad of colicky pain, emesis
and mass. Pediatr Emerg Care 1988, 4:194-196.
45. Green DW, Mimouni F: Neonatal radiology casebook. J Perinatol 1993,
13:235-236.
46. Naik DR, Bolia A, Boon AW: Demonstration of a lactobezoar by
ultrasound. Br J Radiol 1987, 60:506-508.
47. Vallabhaneni P, Mansour M, Hutton K, Banerjee S: Lactobezoar - not so
bizarre! Arch Dis Child Fetal Neonatal Ed 2011, 96:F127, Epub 2010 Nov 16.
Heinz-Erian et al. Orphanet Journal of Rare Diseases 2012, 7:3
http://www.ojrd.com/content/7/1/3
Page 7 of 848. Gittelman MA, Racadio J, Gonzales del Rey J: Radiological case of the
month. Arch Pediatr & Adolesc Med 1999, 153:541-542.
49. Graham RJ, Stein P: Gastric outlet obstruction in an infant: lactobezoar.
Am J Emerg Med 2007, 25:98-99.
50. Mandel D, Lubetzky R, Mimouni FB, Dollberg S: Lactobezoar and
necrotizing enterocolitis in a preterm infant. Isr Med Assoc J 2003,
5:895-896.
51. Colianni S, Ping J, Fischer PR, Freese D: Index of suspicion. Case 1:
lactobezoar. Pediatrics in Review 2004, 25:289-291.
doi:10.1186/1750-1172-7-3
Cite this article as: Heinz-Erian et al.: Gastric lactobezoar - a rare
disorder? Orphanet Journal of Rare Diseases 2012 7:3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Heinz-Erian et al. Orphanet Journal of Rare Diseases 2012, 7:3
http://www.ojrd.com/content/7/1/3
Page 8 of 8